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TO the investigator concerned with the fun- 
damental aspects of endocrine control mecha- 
nisms and the practical application of such 
knowledge, regulation of the secretion of the 
parathyroid and thyroid glands offers much 
that is both challenging and new, and also 
lends itself easily to further development. One 
need look no further than the recent discovery 
of thyrocalcitonin for an example of contem- 
porary endocrinological research which has 
provided not ‘only obvious therapeutic ad- 
vantages (such as the management of hyper- 
parathyroid or hypercalcemic “crisis”), but 
also appears likely to be a key to the under- 
standing of parathyroid control mechanisms 
which heretofore have uniformly thwarted 
investigators working in this area. 
In a more methodical but no less compel- 
ling way, evidence of the participation of the 
central nervous system in the stimulation and 
inhibition of thyroid hormone secretion makes 
it clear that there is a more mature and in- 
clusive control of thyroid secretion than the 
conventional pituitary feedback mechanism. 
This is important not only for its own sake, 
but also as a model of ‘organization that can 
be applied to other endocrine systems pre- 
viously considered to be under exclusive feed- 
back control of the pituitary gland. That 
therapeutic advances may develop from such 
basic information seems highly likely. This 
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brief review seeks to direct interest to some 
of the significant observations contributing to 
these and related advances. 
PARATHYROID GLANDS 
Thyrocalcitonin 
Working independently, Copp et al. [8] and 
Hirsch et al. [22] have identified a hypocalce- 
mic principle which was eventually shown to 
be of thyroid origin and present in a variety 
of mammalian species. Originally designated 
as calcitonin but now more correctly known as 
thyrocalcitonin, this material will promptly 
and efficiently lower the serum calcium of 
many vertebrates, including man. 
Recently Aliapoulous and Watts [l] have 
surveyed a series of human thyroid glands for 
thyrocalcitonin activity. The standard tech- 
nique ‘of utilizing the ability of thyroid gland 
extracts to decrease the serum calcium of rats 
was used as an assay system for the measure- 
ment of thyrocalcitonin activity. In normal 
thyroids removed in conjunction with radical 
surgery for carcinoma of the larynx, thyrocal- 
citonin was consistently found although in 
variable amounts. Autonomous thyroid neo- 
plasms, such as follicular adenoma and papil- 
lary adenocarcinoma, yielded no thyrocalcito- 
nin activity, and a series of patients with 
hyperparathyroidism revealed an apparent 
suppression of thyrocalcitonin since almost no 
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activity was found in the extracts of their 
thyroid glands. Of added interest was an ex- 
tremely high titer of thyrocalcitonin activity 
found in one patient with pseudo-hypopara- 
thyroidism. 
A great deal of work is currently in progress 
which will further define the physiological 
role of thyrocalcitonin more precisely. An ac- 
curate analytical technique, possibly immuno- 
assay, would be most helpful and apparently 
is not beyond solution [I]. 
Critical questions to be answered regarding 
thyrocalcitonin’s activity are: ( 1) what effects 
may this hormone exert on the renal tubular 
excretion of calcium and, (2) to what degree 
is parathyroid hormone secretion physiologi- 
cally influenced by variations in thyrocalcito- 
nin release. It is probable that thyrocalcitonin 
can block the resorption of calcium from bone 
[23, 271 and, it may conceivably influence 
renal tubular transport of calcium as well. It 
is known that serum calcium variations by 
themselves do not change the setting of renal 
mechanisms influencing calcium excretion 
[20]. In addition, Barnes and his co-workers 
[3] have shown a prompt and striking urinary 
conservation of magnesium in subjects on a 
low-magnesium diet who exhibited no changes 
in serum magnesium. Unpublished work from 
the same laboratory has demonstrated a simi- 
lar prompt and strict urinary conservation of 
calcium in subjects placed on a calcium-poor 
diet. Whether or not thyrocalcitonin is impli- 
cated in this sensitive and efficient homeostatic 
response appears to be a question of funda- 
mental importance. It is known that thyrocal- 
citonin will lower the serum calcium and 
phosphate of nephrectomized rats [ 16, 231, a 
finding conceivably related to its action of 
blocking calcium resorption from bone; how- 
ever, there may remain a specific action of 
thyrocalcitonin directly on renal tubular epi- 
thelium. This possibility should be investi- 
gated. 
Thyrocalcitonin has been used successfully 
to reverse so-called parathyroid crisis. It ap- 
pears to be the most rational emergency mea- 
sure available to such patients before definitive 
surgical control of their hyperparathyroidism. 
Intravenous sodium sulfate has been used to 
good advantage in this same situation of hy- 
perparathyroid and hypercalcemic crisis [6]. 
Primary Chief Cell Hyperplda 
Another contemporary insight into parathy- 
roid disease of particular pertinence to sur- 
geons treating hyperparathyroidism is the 
recognition by Cope et al. [7] of the macro- 
scopic appearance of primary chief cell hyper- 
plasia of the parathyroid glands. The diagnosis 
can be made by a perceptive surgeon at the 
operating table. These hyperplastic lesions 
resemble multiple smaIl adenomata grossly. 
The practical significance of this lesion to the 
surgeon is that it is apt to involve all para- 
thyroid tissue. Thus, when it is found to be 
the cause of primary hyperparathyroidism it 
makes mandatory the exposure and subtotal 
resection of all the parathyroid glands rather 
than of just one or two of the more prominent 
parathyroid nodules. 
Diagnosis of Hyperparathyroidism 
A variety of sophisticated diagnostic mea- 
sures have been proposed in hyperparathy- 
roidism. None have proved infallible; the 
diagnosis in difficult and borderline cases 
frequently requires clinical expertness and a 
willingness to observe the disease under well 
controlled conditions of dietary calcium intake 
and over a prolonged time with repeated de- 
terminations of serum calcium and phosphorus 
and urinary calcium and phosphorus excre- 
tion. The hope that latent, mild hyperpara- 
thyroidism might be detectable by loss of 
calcium-conserving ability in response to a 
low-calcium diet has proved fruitless. Hyper- 
parathyroid subjects placed on such diets were 
able to conserve calcium as efficiently as 
normal subjects [ 21. 
The association of pancreatitis and peptic 
ulcer disease with hyperparathyroidism is now 
well established, as is the frequent occurrence 
of hyperparathyroidism in patients with endo- 
crine adenomatosis, including those with the 
Zollinger-Ellison syndrome. Obviously, pa- 
tients with these conditions should be just as 
carefully screened for hyperparathyroidism as 
are patients who have urinary tract calculi. 
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THE THYROID GLAND 
The suspicion that the central nervous sys- 
tem might be involved in the stimulation and 
inhibition of thyroid hormone secretion is not 
a contemporary one even though compelling 
experimental support of it has been developed 
only in the past twenty years. 
Graves in his original description of thyro- 
toxicosis in 1835 [14] referred to a 20-year-old 
female patient who “became affected with 
symptoms supposed to be hysterical; . . . her 
health had previously been good. After she 
had been in this nervous state for three 
months it was observed that her pulse had 
become singularly rapid.” The conviction, on 
clinical grounds, that hyperthyroidism might 
in some instances arise from a background of 
psychic upheaval has been expressed re- 
peatedly. Gibson’s critical review has covered 
much of this material and the interested 
reader is referred to it for amplification of 
this point [13]. 
The earliest experimental suggestions that 
the central nervous system is intimately in- 
volved in the control of the pituitary gland, 
and of thyroid secretion in particular, have 
been amply confirmed but seldom acknowl- 
edged [5, 241. Th e more recent and well 
known observations of Greer [15] showed that 
in rats certain hypothalamic lesions prevented 
thyroid hyperplasia in response to thiouracil, 
a reaction known to depend on the pituitary 
secretion of thyrotropic hormone. This work 
quickly stimulated a number of related obser- 
vations such as noting the ability of hypo- 
thalamic lesions to decrease circulating and 
hypophyseal thyrotropin levels [9] and also to 
decrease thyroidal I 131 uptake and produce 
thyroid atrophy in dogs [ 121. 
In a more direct way Harris and Woods 
stimulated chronically implanted hypothala- 
mic electrodes and demonstrated acute in- 
creases in 1131 release curves from the neck 
region of conscious rabbits [ 171. The validity 
of this technique of measuring thyroid secre- 
tion had previously been established in Profes- 
sor Harris’ laboratory [4]. The time resolution 
of such release curves is several hours, how- 
ever, and it would be useful to apply even 
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more acute techniques, such as those used by 
Soderberg [29], to define more precisely the 
time course of the thyroid response to hypo- 
thalamic stimulation. 
Microinjections of L-thyroxine into the same 
hypothalamic loci have been used to deter- 
mine whether or not a thyroxine-sensitive re- 
ceptor is located in the central nervous system 
[19, 311. In the region of the mammillary 
body and ventromedian hypothalamic nucleus 
such injections are without effect; however, in 
the anterior lobe of the pituitary gland itself, 
identical microinjections will inhibit release 
curves of Iis1 from the neck. Knigge claims to 
have recently developed evidence supporting 
the existence of a thyroxine receptor more an- 
teriorly located in the hypothalamic nuclei- 
in the region of the tuber cinereum [25]. A 
variety of other naturally occurring substances 
of probable significance in central nervous 
transmission of reflex activity (notably epi- 
nephrine and purified substance P) will inhibit 
release curves following microinjection into 
the mammillary body and ventromedian hy- 
pothalamic nucleus [ 191. These substances 
were ineffective elsewhere in the central ner- 
vous system and when directly injected into 
the pituitary. Other catecholamines, specifi- 
cally dopamine and norepinephrine which are 
present in the central nervous system, were 
without any clear effect in any location tested 
[19]. ’ 
This battery of information appears to un- 
equivocally implicate the central nervous sys- 
tem in the control of thyroid secretion. It is 
therefore not at all unreasonable to suppose 
that stimuli of psychic origin arising in the 
central nervous system may stimulate thyroid 
secretion through identical or comparable 
mechanisms, and that on occasion such stimu- 
lation may result in overt thyrotoxicosis. Refer- 
ence has been made to the recurrent clinical 
convictions that hyperthyroidism may occur in 
response to psychic disorder. The excellent de- 
scriptive studies of Lidz can be referred to for 
further development of this concept [26]. Ex- 
perimental approaches to this question have 
been devised and have documented thyroid 
hypersecretion in sheep in response to chronic 
exposure to barking dogs [ll] and to both 
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acute and chronic avoidance conditioning in 
“Executive” monkeys [21, 281. None of these 
techniques is sufficiently established to provide 
the ideal model for experimental production 
of thyroid hypersecretion to the degree seen in 
human thyrotoxicosis. Nevertheless, the ap- 
proach of chronic avoidance conditioning ap- 
pears promising and should be developed 
further. The obvious laboratory expedient of 
producing hypermetabolism by administering 
large doses of exogenous thyroid hormone as 
a model for thyrotoxicosis has some serious 
limitations which are only beginning to be 
realized. This material has been reviewed in 
detail elsewhere [ 181. 
What therapeutic advantages, if any, will 
develop from these insights into the control 
of thyroid secretion is not immediately ap- 
parent. Conceivably, drug treatment directed 
at blocking central nervous system stimulation 
of the thyroid is possible. Therapy of this type 
would be highly desirable because it could 
spare the thyroid from the destructive mea- 
sures now routinely used in the control of 
hyperthyroidism. 
Knowledge of thyroid hormone synthesis 
continues to accumulate, greatly aided by 
double radioactive isotope techniques. A recent 
review of this area by DeGroot summarizes 
this information [lo]. With the development 
of sensitive radio-immunoassay techniques for 
measurements of plasma thyrotropin [ 301, con- 
siderable progress can be expected in under- 
standing the kinetics of thyrotropic hormone 
release from the pituitary gland and variations 
in the thresholds of thyroid gland response to 
thyrotropic hormone. Information of this type 
should be valuable in helping to understand 
the mechanisms by which the persistent and 
dramatic hypersecretion of thyrotoxicosis is 
stimulated. 
SUMMARY 
Contemporary advances continue to develop 
in our understanding of the fundamental phys- 
iology of the control of secretion by the para- 
thyroid and thyroid glands. The discovery of 
thyrocalcitonin and the early research on its 
mechanisms of action gives promise of defin- 
ing many aspects of parathyroid control which 
have been obscure until now. 
Appreciation of central nervous system 
mechanisms influencing thyroid secretion and 
sensitive techniques for thyrotropin measure- 
ment give promise of continued development 
in understanding thyroid secretion control and 
the secretion disorders that commonly occur 
clinically. Direct, obvious and valuable thera- 
peutic advances have resulted from the funda- 
mental approaches used in the study of these 
endocrine glands. Such practical applications 
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